GAITHERSBURG, Md. -- GenVec, Inc. announced a $10 million one-year contract extension of its HIV vaccine development work with the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. The VRC will utilize GenVec's proprietary technologies for vaccine development, including its production cell line, 293-ORF6, to design and test next generation vaccines to optimize the body's immune response to HIV. GenVec is working under a subcontract, issued and managed by SAIC-Frederick, that now totals up to $40 million and extends through 2008.
C. Richter King, PhD, vice president of research at GenVec, stated, "We are pleased to expand our work on developing an effective vaccine to slow or prevent the spread of AIDS. Together with the VRC, we are exploring the design of novel vaccines against the three major HIV strains present worldwide."
One vaccine candidate produced by GenVec is already being tested by the VRC in a phase 1 clinical study designed to assess it for safety and the ability to produce an immune response against HIV. Patient enrollment in this current trial has been completed. In addition to vaccine construction and production, the subcontract includes the use of GenVec's advanced scaleable production process to produce clinical grade HIV vaccine candidates for future NIAID trials.
Source: GenVec, Inc.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.